Prognostic value of smoking status in operated non-small cell lung cancer

P. Sardari Nia, J. Weyler, C. Colpaert, P. Vermeulen, E. Van Marck, P. Van Schil (Antwerp, Belgium)

Source: Annual Congress 2004 - Treatment of lung cancer and lung metastases
Session: Treatment of lung cancer and lung metastases
Session type: Poster Discussion
Number: 376

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Sardari Nia, J. Weyler, C. Colpaert, P. Vermeulen, E. Van Marck, P. Van Schil (Antwerp, Belgium). Prognostic value of smoking status in operated non-small cell lung cancer. Eur Respir J 2004; 24: Suppl. 48, 376

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic value of comorbidity in operated non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 763s
Year: 2006

Prognostic factors in non-small cell lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Prognostic value of apoptotic index in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 5s
Year: 2004

Effect of comorbidity on the prognosis of non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 385s
Year: 2006

Prognostic factors affecting survival in advanced non-small cell lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 75s
Year: 2004

Prognostic factors for unresectable non-small cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 270s
Year: 2002

The prognostic impact of stage and performance status on surgically resected non-small cell lung cancer
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012

Prognostic value of ERCC1 expression in advanced non-small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

Prognostic value of integrated FDG-PET/CT in non-small cell lung cancer
Source: Annual Congress 2008 - New imaging techniques in chest imaging
Year: 2008

Prognostic parameters in non-small cell lung cancer (211 cases)
Source: Eur Respir J 2002; 20: Suppl. 38, 268s
Year: 2002

Effects of prognostic factors on survival of the patients of non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 326s
Year: 2005

Prognostic value of Her2/neu in stage IIIA non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 770s
Year: 2006

Prognostic value study of lung cancer molecular markers and value of mitochondrial activity in resected non-small cell lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

Prognostic  value of  EGFR  genotype  in  EGFR-mutant  non-small  cell lung  cancer
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018

Prognostic factors for non-small cell lung cancer: an analysis of last decade
Source: Eur Respir J 2005; 26: Suppl. 49, 325s
Year: 2005

Prognostic factors in patients with resected pathologic stage I and II nonsmall cell lung cancer (NSCLC)
Source: Eur Respir J 2002; 20: Suppl. 38, 269s
Year: 2002

Validation of the prognostic value of growth pattern classification in operated non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Actual challenges in thoracic surgery
Year: 2010

Importance of weight loss definition in the prognostic evaluation of nonsmall cell lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 477s
Year: 2001

Effects of pretreatment prognostic factors and treatment on survival in advanced nonsmall cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 431s
Year: 2003

Prognostic significance of Nestin in resected non-small cell lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010